Senolytics are the first therapies that directly target one of the aging processes in order to delay or prevent age-related diseases, and they are now in human trials. Today, we think that it is the ideal time to have a look at how they work and what... https://t.co/Iopgt1OV5v
— Lifespan.IO (@LifespanIO) December 27, 2018
No comments:
Post a Comment